Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for Biodesix (BDSX) over the last 6 years, with Q3 2025 value amounting to 0.46%.

  • Biodesix's Return on Capital Employed fell 1000.0% to 0.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.46%, marking a year-over-year decrease of 1000.0%. This contributed to the annual value of 0.41% for FY2024, which is 2500.0% up from last year.
  • Latest data reveals that Biodesix reported Return on Capital Employed of 0.46% as of Q3 2025, which was down 1000.0% from 0.47% recorded in Q2 2025.
  • In the past 5 years, Biodesix's Return on Capital Employed registered a high of 0.2% during Q1 2021, and its lowest value of 1.52% during Q3 2022.
  • Over the past 5 years, Biodesix's median Return on Capital Employed value was 0.58% (recorded in 2024), while the average stood at 0.71%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -11500bps in 2022, then skyrocketed by 6200bps in 2024.
  • Over the past 5 years, Biodesix's Return on Capital Employed (Quarter) stood at 0.76% in 2021, then decreased by -21bps to 0.92% in 2022, then increased by 24bps to 0.69% in 2023, then surged by 42bps to 0.4% in 2024, then fell by -15bps to 0.46% in 2025.
  • Its Return on Capital Employed was 0.46% in Q3 2025, compared to 0.47% in Q2 2025 and 0.42% in Q1 2025.